SCHEMBL3352972

SCHEMBL3352972

COc1ccc(-c2cc(C)nc(N3CCN(C)CC3)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.62
DRD2 P14416 1/20 0.61
HRH4 Q9H3N8 5/20 0.61
CYP2C19 P33261 1/20 0.58
KCNH2 Q12809 1/20 0.58
PTBP1 P26599 2/20 0.52
ALDH1A1 P00352 1/20 0.52
MAPT P10636 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.51
KMT2A Q03164 2/20 0.50
KDM4E B2RXH2 2/20 0.49
HPGD P15428 1/20 0.49
HRH1 P35367 1/20 0.48
MEN1 O00255 1/20 0.48
ALOX15 P16050 1/20 0.48
HTR3E A5X5Y0 1/20 0.48
HTR3B O95264 1/20 0.48
HTR3A P46098 1/20 0.48
HTR3D Q70Z44 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3347629 0.99 HTR6 (0.61) HTR6DRD2HRH4CYP2C19KCNH2
SCHEMBL3345464 0.85 HTR6 (0.57) HTR6DRD2HRH4CYP2C19KCNH2
SCHEMBL3346394 0.83 DRD2 (0.64) HTR6DRD2HRH4ALDH1A1MAPT
SCHEMBL3349828 0.82 HTR6 (0.68) HTR6DRD2HRH4MAPTKMT2A
SCHEMBL3346261 0.77 CYP1A2 (0.57) HTR6DRD2CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL17682471 0.77 DYRK1A (0.63) ALDH1A1MAPTSMN1; SMN2KMT2AKDM4E
SCHEMBL3347950 0.76 HTR6 (1.00) HTR6DRD2HRH4KMT2AHRH1
SCHEMBL11789522 0.76 ALDH1A1 (0.61) HTR6HRH4CYP2C19KCNH2PTBP1
SCHEMBL2166842 0.76 HRH4 (1.00) HRH4HTR3A
SCHEMBL15971252 0.75 HTR6 (1.00) HTR6DRD2HRH4CYP2C19KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO claimed
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO disclosed
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO disclosed